Health
Italian COVID-19 vaccine shows strong immune response in mid-stage trial – bdnews24.com
Italy’s hopes of producing its own COVID-19 vaccine were given a boost on Monday when local biotech firm ReiThera said its vaccine…
The vaccine, called GRAd-COV2, induced an antibody response against the SARS-CoV-2 spike protein in over 93 percent of volunteers three weeks after the first dose, reaching 99 percent after the second dose, the company said in a statement.
However, ReiThera…
Continue Reading
-
General22 hours agoTrump’s trade team chases 90 deals in 90 days
-
Noosa News16 hours agoTalented new artist on jazz scene
-
General22 hours agoGather Round’s first ever Sicko Saturday treats Adelaide Oval to a day of gloriously bad football
-
General21 hours agoClick-bait Bandt | The Spectator Australia